## Abstract ## BACKGROUND The authors conducted a Phase I/II study in patients with a poor prognosis who had locally advanced squamous cell carcinoma of the head and neck (SCCHN) and who were treated initially with induction chemotherapy. Patients were treated with weekly docetaxel and concurrent
Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis
β Scribed by Claude A. Fischer; Minoa Jung; Inti Zlobec; Edith Green; Claudio Storck; Luigi Tornillo; Alessandro Lugli; Markus Wolfensberger; Luigi M. Terracciano
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 334 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Background. Head and neck squamous cell carcinomas (HNSCC) are treated by surgery or radiotherapy. Tumor cell death-related markers, such as p21 and Ki-67, may predict response to therapy and improve treatment choice. We evaluated and compared the effect of their coexpression between patients treated by surgery or radiotherapy.
Methods. Immunohistochemistry for p21 and Ki-67 expression in 144 pharyngeal and laryngeal HNSCC samples was analyzed and correlated with follow-up parameters.
Results. p21 expression correlated significantly with positive cN classification (p < .001), locoregional relapse (p ΒΌ .031), and poor overall survival (p ΒΌ .016), and Ki-67 positivity with poor survival only (p ΒΌ .025). Coexpressing tumor phenotypes showed the worst survival (p ΒΌ .009), observed primarily in patients treated by radiotherapy (p ΒΌ .077).
Conclusions. Coexpression of p21/Ki-67 is a strong negative prognostic factor in HNSCC and could be of particular relevance in tumors treated by primary radiotherapy. V
π SIMILAR VOLUMES
## Abstract Besides wellβknown risk factors such as tobacco use and alcohol consumption, oncogenic human papillomavirus (HPV) infection also has recently been suggested to promote head and neck tumorigenesis. HPV is known to cause cancer by inactivation of cell cycle regulators p53 and pRb via expr
## Abstract ## BACKGROUND: The tumor protein p73 interacts with the human papillomavirus type 16 (HPVβ16) oncoproteins E6 and E7, and __p73__ variation may modify the interaction between p73 protein and HPVβ16 oncogenic proteins and contribute to cellular malignant transformation. ## METHODS: In